India’s New Drug Pricing Policy Could Bring Consolidation For Domestic Market, Price Cuts For Big Pharma
This article was originally published in PharmAsia News
Executive Summary
Set to bring about major changes, India’s proposed drug pricing policy is dubbed by many as “the event of the decade” as large and small players return to the drawing board and brace for tougher market challenges.